Page last updated: 2024-08-20

dextrothyroxine and Central Nervous System Cysticercosis

dextrothyroxine has been researched along with Central Nervous System Cysticercosis in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (50.00)24.3611
2020's1 (50.00)2.80

Authors

AuthorsStudies
da Silva Santana, RC; de Lima, NF; de Sousa Guerra, CH; de Souza Lino Junior, R; Prudente, TP; Vinaud, MC1
Hasbun, R; Samannodi, MS; Zhao, A1

Reviews

1 review(s) available for dextrothyroxine and Central Nervous System Cysticercosis

ArticleYear
Use of Ivermectin in Neurocysticercosis: A Case Report.
    The American journal of case reports, 2018, Nov-20, Volume: 19

    Topics: Adult; Anthelmintics; Central Nervous System Helminthiasis; Dose-Response Relationship, Drug; Drug Administration Schedule; Emergency Service, Hospital; Female; Follow-Up Studies; Humans; Ivermectin; Magnetic Resonance Imaging; Neurocysticercosis; Risk Assessment; Seizures; Treatment Outcome; United States

2018

Other Studies

1 other study(ies) available for dextrothyroxine and Central Nervous System Cysticercosis

ArticleYear
Albendazole - Ivermectin combination decreases inflammation in experimental neurocysticercosis.
    Experimental parasitology, 2023, Volume: 251

    Topics: Albendazole; Animals; Anthelmintics; Anti-Inflammatory Agents; Cysticercus; Inflammation; Ivermectin; Mice; Neurocysticercosis

2023